Friday, August 6, 2021

Medication Guide - 8/6/2021

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Droxia Hydroxyurea CAPSULE;ORAL 016295 BRISTOL MYERS SQUIBB 08/05/2021
Hydrea Hydroxyurea CAPSULE;ORAL 016295 BRISTOL MYERS SQUIBB 08/05/2021
Pomalyst Pomalidomide CAPSULE;ORAL 204026 CELGENE 08/05/2021
Revlimid Lenalidomide CAPSULE;ORAL 021880 CELGENE 08/05/2021
Thalomid Thalidomide CAPSULE;ORAL 020785 CELGENE 08/05/2021
Corlanor Ivabradine Hydrochloride TABLET;ORAL 206143 AMGEN INC 08/04/2021
Corlanor Ivabradine SOLUTION;ORAL 209964 AMGEN INC 08/04/2021
Keytruda Pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 MERCK SHARP DOHME 08/03/2021
Arthrotec Diclofenac Sodium; Misoprostol TABLET, DELAYED RELEASE;ORAL 020607 PFIZER 08/02/2021
Oriahnn (Copackaged) Elagolix Sodium,Estradiol,Norethindrone Acetate; Elagolix Sodium CAPSULE;ORAL 213388 ABBVIE INC 08/02/2021

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment